Renal Denervation Market (By Product: Micro-infusion, Ultrasound, and Radio frequency-based) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global renal denervation market size is expected to reach at USD 1.01 billion in 2026 and is expected to register a CAGR of 41.2% during the forecast period. Increasing incidences of hypertension, changing lifestyle, and long-term positive effect of renal denervation procedure are the key factors driving market. Increasing cases of therapy-resistant hypertension is among one of the prime growth-driving factors for the global renal denervation market. Hypertension is a long term medical condition and is among the most common diseases in the world also without any major symptoms.

Market Dynamics

Availability of improved and alternative technology, such as micro-infusion, for renal denervation systems and better healthcare infrastructures in emerging economies are also expected to enhance market growth. For instance, Mercator MedSystem’s micro-infusion based renal denervation system, reduces the blood pressure in patients, by delivering to its agents at a specific site to denervate the renal artery.

Market Insights

In 2013, according to the Centers for Disease Control and Prevention (CDC), over 3.6lakh people in the U.S. died because of high blood pressure. The occurrence of hypertension has augmented from 17,307 per 100,000 in 1990 to 20,525 per 100,000 in 2015. However, the renal denervation therapy has also shown a optimistic result in minimizing hypertension. Consequently, the advantages offered by such therapies, for instance reduced treatment time, higher safety, and permanent effect are boosting the market growth. Moreover, technological advancement in renal denervation devices is likely to drive the market.

The global renal denervation market in developed economies, such as Italy, the U.K., and France, is moderately mature as compared to other developing and under-developed economies attributable to the presence of major companies in these countries and high awareness and demand among the population for such products. Europe constituted the largest share due to the technological advancements and increase in number of drug-resistant hypertension cases in the regional market.

Market Segmentation

Market By Product

  • Micro-infusion,
  • Ultrasound, and
  • Radio frequency-based

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

In 2017, Europe led the renal denervation market in terms of regions and is anticipated to maintain the dominance even during the forecast period. North America renal denervation market is projected to follow Europe, in terms of revenue generation, during the forecast period due to the increasing number of filings for FDA approvals in the U.S. Rising occurrence of uncontrolled hypertension is also one of the key factors responsible for the North America renal denervation market growth. Asia Pacific renal denervation market is anticipated to experience the fastest growth over the forecast period owing to rising cases of obesity, diabetes, and other lifestyle related diseases. Also, the presence of a large target population base in developing economies like China and Japan are the main drivers for the market growth in Asia Pacific region.

Market Participants

The key players catering to the global renal denervation market are Medtronic PLC; Cardiosonic, Inc.; Kona Medical, Inc.; Abbott Laboratories; Ablative Solutions, Inc.; Renal Dynamics; Mercator MedSystems, Inc.; ReCor Medical, Inc.; Boston Scientific Corp.; and Symple Surgical, Inc. The global players are continuously investing in R&D activities and innovating to have updated technology based product portfolio to attract more and more business opportunity from the emerging nation such as that in Asia Pacific countries.


Related Reports

Systemic Lupus Erythematosus Market (By Drug Classes: NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, Biologics; ByRoute of Administration, Oral, Intravenous, Subcutaneous) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Systemic lupus erythematosus market size is anticipated to around USD 2.7 billion by 2026, this market is anticipated to grow with 7.0% CAGR during the forecast time period. Market Dynamics Biologics for autoimmune conditions enhance treatment to a hug

Continuous Glucose Monitoring (CGM) Systems/Devices Market (By Component: Transmitters & Receivers, Sensors, Insulin Pumps; By End-use: Hospitals, Homecare Settings, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Continuous Glucose Monitoring (CGM) Systems/Devices market size is anticipated to around USD 2.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. Market Dynamics Developing instances of diabetes, comb

Multiparameter Patient Monitoring Market (By Type: Fixed, Portable; By Acuity Level: High-Acuity, Mid-Acuity, Low-Acuity; By Age Group: Adult, Pediatric, Geriatric; By End Use: Hospitals, Homecare Settings, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Multiparameter patient monitoring system is a solution that helps healthcare centres to enhance and improve clinical performance. The multiparameter patient monitors are available in a broad range. The multiparameter patient monitors have various functions such as drug dose calculation, pace detection, paediatric, adult and neonatal monitoring and night mode facility. The report provides analy

Cranial Implants Market (By Product: Non-Customized Cranial Implants, Customized Cranial Implants; By Material: Ceramic, Polymer, Metal; By End-user: Specialty Neurosurgery Centers, Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global cranial implants industry size is examined and is anticipated to value around USD 1.5 billion by the end of 2026. The market is anticipated to develop with a CAGR of 6.4% during the forthcoming years. Market Dynamics The global cranial implants market is d

Chronic Obstructive Pulmonary Disease Treatment Market (By Drug Class: Bronchodilators, Combination, Phosphodiesterase Type 4 Inhibitors, Mucokinetics, Corticosteroids, Others; By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global chronic obstructive pulmonary disease treatment market income is anticipated to value around USD 24.3 billion by the end of 2026. The market is anticipated to develop with a CAGR of 4.9% between the years 2018 to 2026. Market Dynamics The market is driven

Cancer Diagnostics Market (By Type: Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy, Others (barium enema); By Application: Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global cancer diagnostics market size is studied and is anticipated to value around USD 250.3 billion by the end of 2026. The market is anticipated to develop with a CAGR of 7.2% during the forthcoming years. Market Dynamics Developing predominance of oncologic c

Cart Summary